Caroline Ford

 

 


 

Dr Caroline Ford is a cancer researcher within the Adult Cancer Program, Prince of Wales Clinical School at the Lowy Cancer Research Centre. The overall aim of her groups’ research is to understand the key processes in epithelial to mesenchymal transition (EMT) and cancer metastasis, in order to identify targets for novel therapies. Her group focuses on an important signalling pathway involved in metastasis, the Wnt signalling pathway. They are particularly interested in investigating the regulation of a number of key proteins involved in this pathway, and understanding their role in the context of ovarian, endometrial and breast cancer.

After completing her PhD at UNSW on the topic of oncogenic viruses, Dr Ford undertook two international postdoctoral appointments in cancer research. Her first postdoctoral research appointment was at the University of Toronto, Canada and the second appointment was at Lund University, Sweden. She returned to UNSW in late 2009 funded by an NHMRC CJ Martin Fellowship and established the Metastasis Research group within the Adult Cancer Program of which she is the Group Leader.

More info here.




Customize your search:

E.g., 2016-12-03
E.g., 2016-12-03
E.g., 2016-12-03
Sep 19th 2016

Learn about personalised medicine and the impact that our enhanced understanding of genetics has on modern medicine and society. Personalised medicine. Precision medicine. Individualised medicine. Customised medicine. Targeted medicine. All buzzwords of recent years that excite, confuse and infuriate the public, researchers and healthcare professionals. Broadly speaking, these terms all refer to the idea of tailoring treatment to individual patients based on their genetic code.

Average: 10 (1 vote)